Skip to main content

Table 1 Characteristics of CRC patients

From: Colorectal cancer cell-derived CCL20 recruits regulatory T cells to promote chemoresistance via FOXO1/CEBPB/NF-κB signaling

Characteristics

CRC patients with traditional Folfox

CRC patients with neoadjuvant Folfox

CRC patients without Folfox

Number

%

Number

%

Number

%

Gender

 Male

46

52.8

31

56.4

51

49.0

 Female

41

47.1

24

23.1

53

51.0

Age (years)

  < 60

44

50.6

29

52.7

57

54.8

  ≥ 60

43

49.4

26

47.3

47

45.2

Location

 Colon

56

64.4

36

65.5

61

58.7

 Rectum

31

35.6

19

34.5

43

41.3

Tumor size

  < 40 mm

50

57.5

33

60.0

60

57.7

  ≥ 40 mm

37

42.5

22

40.0

44

42.3

Pathological type

 Adenocarcinoma

77

88.5

45

81.8

94

90.3

 Others

10

11.5

10

18.2

10

9.6

Lymph node metastasis

 Yes

41

47.1

25

45.5

53

51.0

 No

46

52.9

30

54.5

51

49.0

Distant metastasis

 Yes

34

39.1

27

49.0

23

22.1

 No

53

60.9

28

50.9

81

77.9

TNM Stage

 I

5

5.7

5

9.0

12

11.5

 II

36

41.4

18

32.7

39

37.5

 III

25

28.7

6

10.9

30

28.8

 IV

21

24.1

27

49.0

23

22.1

Differentiation

 Low

5

5.7

7

12.7

6

5.7

 Low-moderate

15

17.2

10

18.2

18

17.3

 Moderate

67

77.0

38

69.1

80

74.8